Inhibition of rat corneal angiogenesis by 16-kDa prolactin and by endogenous prolactin-like molecules.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Investigative Ophthalmology and Visual Science

• Publication date

  1999-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 10509642
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of urokinase activity by the antiangiogenic factor 16K prolactin: activation of plasminogen activator inhibitor 1 expression.

  1998cited by this paper
• Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice.

  1998cited by this paper
• Expression of prolactin mRNA and of prolactin-like proteins in endothelial cells: evidence for autocrine effects.

  1998cited by this paper
• Molecular mechanisms of blood vessel formation.

  1997cited by this paper
• Prolactins: Novel Regulators of Angiogenesis

  1997cited by this paper
• Endostatin: an endogenous inhibitor of angiogenesis and tumor growth.

  1997cited by this paper
• Angiogenesis and angiogenesis inhibition: an overview.

  1997cited by this paper
• Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells.

  1996cited by this paper
• Regulation of Angiogenesis

  1996cited by this paper
• Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects

  1995cited by this paper
• Angiogenesis in cancer, vascular, rheumatoid and other disease

  1995cited by this paper
• Role of B61, the ligand for the Eck receptor tyrosine kinase, in TNF-alpha-induced angiogenesis.

  1995cited by this paper
• Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin.

  1995cited by this paper
• A 14-kilodalton prolactin-like fragment is secreted by the hypothalamo-neurohypophyseal system of the rat.

  1995cited by this paper
• A potent inhibitor of endothelial cell proliferation is generated by proteolytic cleavage of the chemokine platelet factor 4.

  1995cited by this paper
• Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma.

  1994cited by this paper
• Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

  1994cited by this paper
• The prolactin gene is expressed in the hypothalamic-neurohypophyseal system and the protein is processed into a 14-kDa fragment with activity like 16-kDa prolactin.

  1994influential reference
• Stimulation and inhibition of angiogenesis by placental proliferin and proliferin-related protein.

  1994influential reference
• Angiogenesis inhibition: a review.

  1994cited by this paper
• Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects.

  1993cited by this paper
• The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis.

  1993influential reference
• A specific, high affinity, saturable binding site for the 16-kilodalton fragment of prolactin on capillary endothelial cells.

  1992influential reference
• Prolactin localization, binding, and effects on peroxidase release in rat exorbital lacrimal gland.

  1992influential reference
• An Epstein-Barr virus-negative Burkitt lymphoma cell line (sfRamos) secretes a prolactin-like protein during continuous growth in serum-free medium.

  1991cited by this paper
• Inhibition of angiogenesis and tumor growth by a synthetic laminin peptide, CDPGYIGSR-NH2.

  1991cited by this paper
• Assays for angiogenesis: a review.

  1991cited by this paper
• Temperature dependence of prolactin endocytosis and casein exocytosis in epithelial mammary cells.

  1991cited by this paper
• Assay and purification of naturally occurring inhibitor of angiogenesis.

  1991cited by this paper
• The 16K fragment of prolactin specifically inhibits basal or fibroblast growth factor stimulated growth of capillary endothelial cells.

  1991influential reference
• Identification of an inhibitor of neovascularization from cartilage.

  1990cited by this paper
• A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin.

  1990cited by this paper
• Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy.

  1990cited by this paper
• Characterization and applications of monoclonal antibodies to the prolactin receptor.

  1989cited by this paper
• Analysis of the proteolytic cleavage of prolactin by the mammary gland and liver of the rat: characterization of the cleaved and 16K forms.

  1987cited by this paper
• Monoclonal antibodies against human, bovine and rat prolactin: epitope mapping of human prolactin and development of a two-site immunoradiometric assay.

  1987cited by this paper
• The preocular tear film : in health, disease, and contact lens wear

  1986cited by this paper
• An enzyme-linked immunosorbent assay for rat prolactin.

  1984cited by this paper
• The uptake of prolactin into female rat liver. Concentration of intact hormone in the Golgi apparatus.

  1979cited by this paper
• Prolactin-thyroxine antagonism and the metamorphosis of visual pigments in Rana catesbeiana tadpoles.

  1975cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• Topical ophthalmic administration of the antiangiogenic peptide VIAN-c4551 protects against experimental diabetic macular edema

  2025cites this paper
• Topical Ophthalmic Administration of VIAN-c4551 Antiangiogenic Peptide for Diabetic Macular Edema: Preclinical Efficacy and Ocular Pharmacokinetics

  2024cites this paper
• The influence of the prolactin/vasoinhibin axis on post‐stroke lesion volume, astrogliosis, and survival

  2024cites this paper
• Levosulpiride for the treatment of diabetic macular oedema: a phase 2 randomized clinical trial

  2023cites this paper
• The apoptotic, inflammatory, and fibrinolytic actions of vasoinhibin are in a motif different from its antiangiogenic HGR motif

  2023cites this paper
• Vasoinhibin’s Apoptotic, Inflammatory, and Fibrinolytic Actions Are in a Motif Different From Its Antiangiogenic HGR Motif

  2023cites this paper
• Prolactin and vasoinhibin are endogenous players in diabetic retinopathy revisited

  2022cites this paper
• Sulpiride‐induced hyperprolactinaemia increases retinal vasoinhibin and protects against diabetic retinopathy in rats

  2022cites this paper
• Vasoinhibin is Generated and Promotes Inflammation in Mild Antigen-Induced Arthritis.

  2022cites this paper
• Prolactin stimulates the vascularisation of the retina in newborn mice under hyperoxia conditions

  2020cites this paper
• Vasoinhibin generation and effect on neuronal apoptosis in the hippocampus of late mouse embryos.

  2020cites this paper
• Levosulpiride Increases the Levels of Prolactin and Antiangiogenic Vasoinhibin in the Vitreous of Patients with Proliferative Diabetic Retinopathy

  2020cites this paper
• Regulator of Angiogenesis and Vascular Function: A 2019 Update of the Vasoinhibin Nomenclature

  2019cites this paper
• Sequence optimization and glycosylation of vasoinhibin: Pitfalls of recombinant production.

  2019cites this paper
• JAK2/STAT5 Pathway Mediates Prolactin-Induced Apoptosis of Lactotropes

  2018cites this paper
• Basis and Design of a Randomized Clinical Trial to Evaluate the Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema

  2018cites this paper
• Anti-angiogenic effect of hexahydrocurcumin in rat corneal neovascularization

  2018cites this paper
• Human Prolactin Point Mutations and Their Projected Effect on Vasoinhibin Generation and Vasoinhibin-Related Diseases

  2017cites this paper
• From Bench to Bedside: Translating the Prolactin/Vasoinhibin Axis

  2017cites this paper
• Higher prolactin and vasoinhibin serum levels associated with incidence and progression of retinopathy of prematurity

  2017cites this paper
• TFOS DEWS II Sex, Gender, and Hormones Report.

  2017cites this paper
• Current and Upcoming Therapies for Ocular Surface Chemical Injuries.

  2017cites this paper
• The role of the prolactin/vasoinhibin axis in rheumatoid arthritis: an integrative overview

  2016cites this paper
• Increased retinal vasopermeability (RVP) occurs early in diabetes and is crucial for the development of sight-threatening proliferative diabetic retinopathy (DR). Prolactin has protective role in diabetes and diabetic retinopathy, it is acts on pancreatic β-cell to stimulate proliferation, survival,

  2016cites this paper
• A positive feedback loop between prolactin and STAT5 promotes angiogenesis.

  2015cites this paper
• Traitements comparés de la néovascularisation cornéenne : injections sous-conjonctivales de bévacizumab et/ou photothérapie dynamique

  2015cites this paper
• [Corneal neovascularisation treatments compared: Subconjunctival bevacizumab injections and/or photodynamic therapy].

  2015cites this paper
• Prolactin-derived vasoinhibins increase anxiety- and depression-related behaviors.

  2014cites this paper
• Hyperprolactinemia impairs object recognition without altering spatial learning in male rats.

  2013cites this paper
• The effects of maternal diabetes on the glomerular and buman volume and tubular changes in newborn rats

  2013cites this paper
• STAT5 and Prolactin Participate in a Positive Autocrine Feedback Loop That Promotes Angiogenesis*

  2013cites this paper
• Extrapituitary production of anterior pituitary hormones: an overview

  2012cites this paper
• Prolactin and its 16-kDa N-terminal fragment: are higher in patients with precapillary pulmonary hypertension than in a healthy control group.

  2012cites this paper
• Prolactin and vasoinhibins: Endogenous players in diabetic retinopathy

  2011cites this paper
• Comparison of the antiangiogenic activity of modified RGDRGD-endostatin to endostatin delivered by gene transfer in vivo rabbit neovascularization model

  2011cites this paper
• Inhibition of mouse alkali burn induced-corneal neovascularization by recombinant adenovirus encoding human vasohibin-1

  2010cites this paper
• Thrombospondin-1 as a Paradigm for the Development of Antiangiogenic Agents Endowed with Multiple Mechanisms of Action

  2010cites this paper
• Novel aspects of corneal angiogenic and lymphangiogenic privilege.

  2010cites this paper
• Ocular angiogenesis: mechanisms and recent advances in therapy.

  2010cites this paper
• A lacrimal gland is a lacrimal gland, but rodent's and rabbit's are not human.

  2010cites this paper
• Effects of prolactin deficiency during the early postnatal period on the development of maternal behavior in female rats: mother's milk makes the difference.

  2009cites this paper
• Cathepsin D is the primary protease for the generation of adenohypophyseal vasoinhibins: cleavage occurs within the prolactin secretory granules.

  2009cites this paper
• Subconjunctival gene delivery of the transcription factor GA-binding protein delays corneal neovascularization in a mouse model

  2009cites this paper
• Prolactin in Ovarian Follicular Fluid Stimulates Endothelial Cell Proliferation

  2009cites this paper
• Peptide hormone regulation of angiogenesis.

  2009cites this paper
• Vasoinhibins: novel inhibitors of ocular angiogenesis.

  2008cites this paper
• Role of Prolactin and Vasoinhibins in the Regulation of Vascular Function in Mammary Gland

  2008cites this paper
• Integrin alphavbeta3 is not significantly implicated in the anti-migratory effect of anti-angiogenic urokinase kringle domain.

  2008cites this paper
• Maternal hyperglycemia proliferate choroid plexus and enlarge the lateral ventricle in brain of newborn rats

  2008cites this paper
• Subconjunctival injection of recombinant AAV-angiostatin ameliorates alkali burn induced corneal angiogenesis.

  2007cites this paper
• Elevated vasoinhibins may contribute to endothelial cell dysfunction and low birth weight in preeclampsia

  2007cites this paper
• [Diabetic retinopathy and vasoinhibins].

  2007cites this paper
• Tear analysis and lens-tear interactions. Part I. Protein fingerprinting with microfluidic technology.

  2007cites this paper
• Photodynamic therapy with verteporfin for corneal neovascularization.

  2007cites this paper
• Inhibition of corneal neovascularization with endostatin delivered by adeno-associated viral (AAV) vector in a mouse corneal injury model.

  2007cites this paper
• 16-kDa prolactin inhibits endothelial cell migration by down-regulating the Ras-Tiam1-Rac1-Pak1 signaling pathway.

  2007cites this paper
• Fibroblast growth factors/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategies.

  2007cites this paper
• Aptamer-based therapeutics and their potential in radiopharmaceutical design

  2007cites this paper
• CHAPTER 32 – Prolactin: Structure, Function, and Regulation of Secretion

  2006cites this paper
• Vasoinhibins: endogenous regulators of angiogenesis and vascular function.

  2006cites this paper
• Experimental Inhibition of Corneal Neovascularization by Photodynamic Therapy with Verteporfin

  2006cites this paper
• Opposite Association of Serum Prolactin and Survival in Patients with Colon and Rectal Carcinomas: Influence of Preoperative Radiotherapy

  2006cites this paper
• A molecular mimic demonstrates that phosphorylated human prolactin is a potent anti-angiogenic hormone.

  2006cites this paper
• Vasoinhibins: a family of N-terminal prolactin fragments that inhibit angiogenesis and vascular function.

  2006cites this paper
• Matrix metalloproteases from chondrocytes generate an antiangiogenic 16 kDa prolactin

  2006cites this paper
• Angiogenesis in the female reproductive system.

  2005cites this paper
• Inhibition of corneal angiogenesis by local application of vasostatin.

  2005cites this paper
• Prolactins are natural inhibitors of angiogenesis in the retina.

  2005cites this paper
• Testing the Angiogenic Potential of Cerebrovascular Malformations by Use of a Rat Cornea Model: Usefulness and Novel Assessment of Changes over Time

  2005cites this paper
• Lipid-mediated delivery of brain-specific angiogenesis inhibitor 1 gene reduces corneal neovascularization in an in vivo rabbit model

  2005cites this paper
• 16-kDa prolactin down-regulates inducible nitric oxide synthase expression through inhibition of the signal transducer and activator of transcription 1/IFN regulatory factor-1 pathway.

  2005cites this paper
• Angiogenesis in Prolactinomas: Regulation and Relationship with Tumour Behaviour

  2005cites this paper
• Morphologic changes and molecular regulation of angiogenesis in pituitary adenomas.

  2004cites this paper
• 16K-prolactin inhibits activation of endothelial nitric oxide synthase, intracellular calcium mobilization, and endothelium-dependent vasorelaxation.

  2004cites this paper
• Prolactin in eyes of patients with retinopathy of prematurity: implications for vascular regression.

  2004cites this paper
• Molecular targeting of antiangiogenic factor 16K hPRL inhibits oxygen-induced retinopathy in mice.

  2004cites this paper
• Anti-angiogenic role of angiostatin during corneal wound healing.

  2004cites this paper
• In vivo release and gene upregulation of brain prolactin in response to physiological stimuli

  2004cites this paper
• Prolactin gene expression in mouse spleen helper T cells.

  2004cites this paper
• Hypoxia Inhibits Expression of Prolactin and Secretion of Cathepsin-D by the GH4C1 Pituitary Adenoma Cell Line

  2003cites this paper
• Expression and purification of the angiogenesis inhibitor 16-kDa prolactin fragment from insect cells.

  2003cites this paper
• Antitumor activity of the 16-kDa prolactin fragment in prostate cancer.

  2003cites this paper
• Immortalization of bovine umbilical vein endothelial cells: a model for the study of vascular endothelium.

  2002cites this paper
• Angiostatin inhibits and regresses corneal neovascularization.

  2002cites this paper
• Inhibitors of Angiogenesis

  2002cites this paper
• RAPID COMMUNICATION 16K Prolactin induces NF-B activation in pulmonary fibroblasts

  2002cites this paper
• Roles of prolactin and related members of the prolactin/growth hormone/placental lactogen family in angiogenesis.

  2002influential citation
• Expression of the antiangiogenic factor 16K hPRL in human HCT116 colon cancer cells inhibits tumor growth in Rag1(-/-) mice.

  2001cites this paper
• Structure-Function Relationships in Prolactin

  2001cites this paper
• Vascular Morphogenesis in the Mammary Gland: Introduction and Overview

  2001cites this paper
• Expression of prolactin gene and secretion of prolactin by rat retinal capillary endothelial cells.

  2001influential citation
• Human umbilical vein endothelial cells express multiple prolactin isoforms.

  2000influential citation
• Effects of prolactin on osteoblast alkaline phosphatase and bone formation in the developing rat.

  2000cites this paper